MedTrace Logo

Bioavailability Study of Colcrys® in Apple Juice

NCT01123395 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2011-05-03

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate and compare the relative bioavailability of a single 0.6 mg tablet of Colcrys® (colchicine, USP) when crushed and dissolved in apple juice relative to the same dose given as an intact tablet to healthy subjects following an overnight fast.

Conditions

  • Healthy

Interventions

DRUG

colchicine 0.6 mg tablet

One Colcrys® 0.6 mg intact tablet taken by mouth

DRUG

colchicine 0.6 mg tablet

One Colcrys® 0.6 mg tablet dissolved in apple juice

Sponsors & Collaborators

  • Mutual Pharmaceutical Company, Inc.

    lead INDUSTRY

Principal Investigators

  • Darin B Brimhall, D.O. · Novum Pharmaceutical Research Services

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01123395 on ClinicalTrials.gov